血浆脂联素与哮喘风险:观察性分析、孟德尔随机化及荟萃分析
该研究在哥本哈根普通人群研究中观察性分析28 845人(2 278例哮喘),并在94 868人(7 128例哮喘)中行单样本孟德尔随机化;另在英国生物银行462 933人(53 598例哮喘)中行双样本孟德尔随机化并荟萃分析。观察性分析显示血浆脂联素每升高1单位(对数转换)与哮喘风险增加相关(OR 1.65, 95%CI 1.29-2.08),但遗传因果分析未支持因果关联。
要点
- 观察性分析中血浆脂联素升高与哮喘风险增加相关(OR 1.65)。
- 孟德尔随机化分析未发现脂联素对哮喘的因果效应。
- 脂联素作为哮喘治疗靶点的证据不足。
核心结论
- 观察性分析显示高血浆脂联素与哮喘风险增加相关,但遗传证据不支持因果关联。
研究设计与样本
- 哥本哈根普通人群研究:观察性分析28 845人(2 278例哮喘),单样本孟德尔随机化94 868人(7 128例哮喘)使用4个遗传变异。
- 英国生物银行:双样本孟德尔随机化462 933人(53 598例哮喘)使用12个遗传变异,并对遗传发现进行荟萃分析。
主要发现
- 哥本哈根研究中,血浆脂联素每升高1单位(对数转换)与哮喘观察性OR 1.65(95%CI 1.29-2.08)相关。
- 哥本哈根研究中,遗传因果OR为1.03(95%CI 0.75-1.42)。
- 英国生物银行中,遗传因果OR为1.00(95%CI 0.99-1.00)。
- 遗传荟萃分析证实遗传预测的高血浆脂联素与哮喘无因果关联。
临床怎么用
- 临床不应将脂联素作为哮喘的因果治疗靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adiponectin, an adipocyte-secreted protein-hormone with inflammatory properties, has a potentially important role in the development and progression of asthma. Unravelling whether adiponectin is a causal risk factor for asthma is an important issue to clarify as adiponectin could be a potential novel drug target for the treatment of asthma. OBJECTIVE: We tested the hypothesis that plasma adiponectin is associated observationally and causally (using genetic variants as instrumental variables) with risk of asthma. METHODS: In the Copenhagen General Population Study, we did an observational analysis in 28 845 individuals (2278 asthma cases) with plasma adiponectin measurements, and a genetic one-sample Mendelian randomisation analysis in 94 868 individuals (7128 asthma cases) with 4 genetic variants. Furthermore, in the UK Biobank, we did a genetic two-sample Mendelian randomisation analysis in 462 933 individuals (53 598 asthma cases) with 12 genetic variants. Lastly, we meta-analysed the genetic findings. RESULTS: While a 1 unit log-transformed higher plasma adiponectin in the Copenhagen General Population Study was associated with an observational OR of 1.65 (95% CI 1.29 to 2.08) for asthma, the corresponding genetic causal OR was 1.03 (95% CI 0.75 to 1.42). The genetic causal OR for asthma in the UK Biobank was 1.00 (95% CI 0.99 to 1.00). Lastly, genetic meta-analysis confirmed lack of association between genetically high plasma adiponectin and causal OR for asthma. CONCLUSION: Observationally, high plasma adiponectin is associated with increased risk of asthma; however, genetic evidence could not support a causal association between plasma adiponectin and asthma.
引用
- Nielsen MB, Nordestgaard BG, Benn M, et al. Plasma adiponectin and risk of asthma: observational analysis, genetic Mendelian randomisation and meta-analysis. Thorax. 2021. PMID: 34949725. doi:10.1136/thoraxjnl-2021-217675
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。